Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ascletis Pharma Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $176.41M | $99.25M - $253.57M | -$176.41M | -$0.361 | 1 |
| Dec 2027 | $71.13M | $40.02M - $102.24M | -$71.13M | -$0.359 | 2 |
| Dec 2026 | $817.06M | $459.70M - $1.17B | -$817.06M | $0.444 | 2 |
| Dec 2025 | $1.08M | $608.0K - $1.55M | -$1.08M | -$0.37 | 4 |
| Dec 2024 | $18.74M | $10.54M - $26.93M | -$18.74M | -$0.247 | 3 |
| Dec 2023 | $54.45M | $54.45M - $54.45M | -$54.45M | -$0.119 | 2 |
| Dec 2022 | $136.38M | $136.38M - $136.38M | -$136.38M | -$0.144 | 1 |
| Dec 2021 | $76.37M | $76.37M - $76.37M | -$76.37M | -$0.09 | 2 |
| Dec 2020 | $186.82M | $186.82M - $186.82M | -$186.82M | $0.07 | 2 |
| Dec 2019 | $162.58M | $162.58M - $162.58M | -$162.58M | -$0.114 | 1 |
| Dec 2018 | $135.43M | $135.43M - $135.43M | -$135.43M | $0.033 | 2 |